Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACTAVIS ELIZABETH

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 26
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text

AM REGENT

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 26
  • 0 comments

FDA approve HYDRALAZINE HYDROCHLORIDE

Comment Full text

ALEMBIC

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 25
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

APOTEX

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 24
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 29, 2024, 08:45 UTC
  • 25
  • 0 comments

FDA approve EZETIMIBE

Comment Full text

SCHERING

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 29
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

MSD MERCK CO

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 26
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

MAYNE PHARMA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 23
  • 0 comments

FDA approve ITRACONAZOLE

Comment Full text

SHANDONG XINHUA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 29
  • 0 comments

FDA approve SEVELAMER CARBONATE

Comment Full text

BARR

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 26
  • 0 comments

FDA approve ISONIAZID

Comment Full text
  • Previous
  • 231
  • 232
  • 233
  • 234
  • 235
  • Next

Search

News categories

  • Technical Exchange News(9921)
  • Event(412)
  • SEC News(167881)
  • FDA Approval(9362)
  • Company Report(721)
  • Business News(111713)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin